| Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion. M Botana-Rial, P Casado-Rey, V Leiro-Fernandez, M Andrade-Olivié, ... Clinical laboratory 57 (5-6), 373-378, 2011 | 31 | 2011 |
| Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study C Mouronte-Roibás, V Leiro-Fernández, A Ruano-Raviña, ... Respiratory Research 20, 1-10, 2019 | 18 | 2019 |
| Validation of calprotectin as a novel biomarker for the diagnosis of pleural effusion: a multicentre trial M Botana-Rial, L Vázquez-Iglesias, P Casado-Rey, MP Cadena, ... Scientific reports 10 (1), 5679, 2020 | 15 | 2020 |
| Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme … L Bouzas, FJ Ortega, P Casado, MI Arranz, A Carcas, JC Tutor Clinical Laboratory 53 (9-12), 591-596, 2007 | 7 | 2007 |
| Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid L Vazquez-Iglesias, P Casado-Rey, M Botana-Rial, MA Andrade-Olivie, ... Clinical Chemistry and Laboratory Medicine (CCLM) 55 (8), e172-e174, 2017 | 6 | 2017 |
| A rapid calprotectin test for the diagnosis of pleural effusion P Casado-Rey, L Vázquez-Iglesias, M Botana-Rial, MA Andrade-Olivié, ... Plos one 16 (6), e0252714, 2021 | 4 | 2021 |
| Calprotectina en líquido pleural: nueva aproximación diagnóstica del derrame pleural P Casado Rey Programa de doutoramento en Metodoloxía e Aplicacións en Ciencias da Vida …, 2021 | | 2021 |
| Analysis of the demand for testing drugs of abuse in the Emergency Clinical Laboratory during 2006-2010 PC Rey, RD Garcia, MP Perez, PE Dominguez, MAA Olivie THERAPEUTIC DRUG MONITORING 33 (4), 496-496, 2011 | | 2011 |
